<DOC>
	<DOCNO>NCT01691664</DOCNO>
	<brief_summary>Cytokine-induced killer ( CIK ) cell show cytolytic activity tumor . Radiation therapy use high-energy x-rays damage tumor cell . Combining Radiation therapy adoptive cellular therapy surgery may effective us radiation therapy alone treat esophageal cancer .</brief_summary>
	<brief_title>Adoptive Cellular Therapy Radiation Therapy After Surgery Treating Patients With Esophageal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>cytologically histologically confirm esophageal carcinoma Tumor extension beyond muscularis propria and/or nodal involvement without evidence M1 disease Prior en bloc resection , curative intent , know tumor No metastatic disease Age : &gt; 18 Karnofsky performance status ≥ 70 At least 3 week since prior surgery Normal function heart , lung , liver , kidney bone marrow Blood exam qualify chemotherapy , include hemoglobulin ≥9 g/dl , neutrophil ≥1.5×109/L platelet ( PLT ) ≥100×109/L , creatinine ≤1.5 UNL All patient must evaluate radiation oncologist prior enrollment ensure patient appropriate radiotherapy Informed consent sign Patients metastatic disease . Patients pregnant nursing . Patients poor bone marrow , liver kidney function , would make radiation therapy intolerable Patients contraindication irradiation : complete obstruction esophagus , deep esophageal ulcer , fistula mediastinum , haematemesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Esophageal Cancer</keyword>
	<keyword>DC-CIK</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>cellular therapy</keyword>
	<keyword>radiation therapy</keyword>
</DOC>